SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-040463
Filing Date
2024-09-06
Accepted
2024-09-06 16:07:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A ef20035567_defa14a.htm DEFA14A 13642
2 image00001.jpg GRAPHIC 3255
  Complete submission text file 0001140361-24-040463.txt   19278
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-649-9272
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-35776 | Film No.: 241284564
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)